{
  "docId": "019de075-e109-770f-8f32-3054686041b6",
  "docSlug": "9819f3512e565b918c6cfc8e3688cfb2",
  "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Spyre Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 38,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-e109-770f-8f32-3054686041b6/26",
  "deckHref": "/decks/019de075-e109-770f-8f32-3054686041b6",
  "deckJsonHref": "/decks/019de075-e109-770f-8f32-3054686041b6.json",
  "deckAnchorHref": "/decks/019de075-e109-770f-8f32-3054686041b6#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.076,
        "w": 0.368,
        "x": 0.632,
        "y": 0.675
      },
      "kind": "callout",
      "text": "INTERIM PHASE 1 PK DATA EXPECTED 1H2025",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ba12ae0-0bfc-4aa7-afd8-875a0f7c9f1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.06,
        "x": 0.736,
        "y": 0.298
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "909a5d6a-926a-45b1-9cb4-8677c6db2ac4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.06,
        "x": 0.234,
        "y": 0.308
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e4486a50-820d-405f-a13c-8b33e68f38f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.06,
        "x": 0.477,
        "y": 0.303
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f95f0ca0-9193-4def-8b63-694a75ec0ddb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.058,
        "w": 0.296,
        "x": 0.106,
        "y": 0.47
      },
      "kind": "paragraph",
      "text": "LEAD CLONES ARE MONOMER AND TRIMER BINDERS WITH POTENCY DESIGNED TO BE SUPERIOR TO SELECT ANTIBODIES",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "503f7901-d0b2-4fe0-b433-ed28536d9e2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.058,
        "w": 0.23,
        "x": 0.392,
        "y": 0.467
      },
      "kind": "paragraph",
      "text": "ONLY KNOWN EXTENDED HALF-LIFE TL1A ANTIBODY IN DEVELOPMENT",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b3f1525-55a0-4758-aa5f-82f27366264e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.058,
        "w": 0.23,
        "x": 0.657,
        "y": 0.467
      },
      "kind": "paragraph",
      "text": "DEVELOPING PATIENT SELECTION APPROACHES TO IDENTIFY RESPONDERS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3fb4966-468d-4819-ab47-2d9ffd4a333c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.092,
        "w": 0.287,
        "x": 0.026,
        "y": 0.042
      },
      "kind": "title",
      "text": "SPY002 summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d217ea4a-2636-44db-bf57-4727941a2976",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "c446bbef-a7ef-4c78-b6b9-f6bfe5d28bc5",
      "evidence": "paragraph/paragraph: LEAD CLONES ARE MONOMER AND TRIMER BINDERS WITH POTENCY DESIGNED TO BE SUPERIOR TO SELECT ANTIBODIES",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}